title: The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo.
abstract: The activity of 51 synthetic cis-fused cyclopenteno-1,2,4-trioxanes has been examined against drug-sensitive and chloroquine-resistant malaria parasites in vivo. Some of them display high levels of blood schizontocidal activity when administered orally or subcutaneously. They retain their activity against lines of parasites that are resistant to widely differing antimalarials such as 4-aminoquinolines, aminoalcohols, dihydrofolate reductase inhibitors and artemisinin. The most potent compound of the present series is cis-(+/-)-4a,7a-dihydro-6,7a-di(p-fluorophenyl)spiro [cyclopentane-3,3'-7H-cyclopenta-1,2,4-trioxin], otherwise known as Fenozan-50F.
authors.affiliation: CAB International Institute of Parasitology, St. Albans, Hertfordshire, U.K.
authors.forename: W
authors.initials: W
authors.lastname: Peters
authors.forename: B L
authors.initials: BL
authors.lastname: Robinson
authors.forename: J C
authors.initials: JC
authors.lastname: Rossier
authors.forename: D
authors.initials: D
authors.lastname: Misra
authors.forename: C W
authors.initials: CW
authors.lastname: Jefford
authors.forename: J C
authors.initials: JC
authors.lastname: Rossiter
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D005260:Female; D008288:Malaria / Q000188:drug therapy*; D051379:Mice; D010666:Phenylpropionates / Q000627:therapeutic use*; D010962:Plasmodium berghei / Q000187:drug effects*; D010967:Plasmodium yoelii / Q000187:drug effects*; D013329:Structure-Activity Relationship
chemical_list: D000962:Antimalarials; D010666:Phenylpropionates; C047854:fenozan